SCHEMBL6565713

SCHEMBL6565713

CCC(=O)c1cc(N)ccc1OCc1ccc(C)cc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4A O75164 1/20 0.39
KDM5A P29375 1/20 0.39
KDM2B Q8NHM5 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
KDM5B Q9UGL1 1/20 0.39
ALDH1A1 P00352 2/20 0.39
MRGPRX4 Q96LA9 1/20 0.38
POLB P06746 2/20 0.37
PARP1 P09874 1/20 0.37
AKR1C1 Q04828 1/20 0.37
FFAR4 Q5NUL3 3/20 0.37
FFAR1 O14842 2/20 0.37
HTR2A P28223 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6565808 0.83 KMT2A (0.46) ALDH1A1POLBPARP1FFAR4FFAR1
SCHEMBL6566711 0.81 CYP19A1 (0.46) ALDH1A1POLBL3MBTL1LMNAMAPT
SCHEMBL9133739 0.79 LRRK2 (0.53) ALDH1A1LMNAMAPT
SCHEMBL6567679 0.78 HDAC8 (0.47) ALDH1A1MRGPRX4FFAR4FFAR1LMNA
SCHEMBL6567010 0.77 RAB9A (0.50) POLBLMNAMAPT
SCHEMBL6564598 0.76 SMN1; SMN2 (0.48) ALDH1A1POLBPARP1HTR2ALMNA
SCHEMBL22419890 0.76 ALDH1A1 (0.53) KDM4CALDH1A1L3MBTL1LMNAMAPT
SCHEMBL6566807 0.76 MAPT (0.52) ALDH1A1POLBLMNAMAPT
SCHEMBL6568009 0.74 PTGDR2 (0.55) ALDH1A1POLBHTR2AL3MBTL1LMNA
SCHEMBL6568120 0.74 MAPT (0.54) ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 KDM4A 2499/4885KDM5A 1558/4885KDM2B 2792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.